within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H03B_AntithyroidPreparations.H03BB01_Carbimazole;

model Carbimazole
  extends Pharmacolibrary.Drugs.ATC.H.H03BB01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>H03BB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Carbimazole is an antithyroid medication that is used to treat hyperthyroidism (overactive thyroid gland), most commonly in conditions such as Graves' disease. It works by inhibiting the synthesis of thyroid hormones. Carbimazole is a prodrug and is rapidly converted in vivo to methimazole, its active metabolite. It is widely approved and used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from published studies in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Skellern, GG, et al., &amp; Kalk, WJ (1980). The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients. <i>British journal of clinical pharmacology</i> 9(2) 137–143. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1980.tb05823.x&quot;>10.1111/j.1365-2125.1980.tb05823.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7356900/&quot;>https://pubmed.ncbi.nlm.nih.gov/7356900</a></p></li><li><p>Skellern, GG, et al., &amp; Alexander, WD (1980). The pharmacokinetics of methimazole in pregnant patients after oral administration of carbimazole. <i>British journal of clinical pharmacology</i> 9(2) 145–147. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1980.tb05824.x&quot;>10.1111/j.1365-2125.1980.tb05824.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7356901/&quot;>https://pubmed.ncbi.nlm.nih.gov/7356901</a></p></li><li><p>Frénais, R, et al., &amp; Horspool, LJ (2008). Pharmacokinetics of controlled-release carbimazole tablets support once daily dosing in cats. <i>Journal of veterinary pharmacology and therapeutics</i> 31(3) 213–219. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2885.2008.00949.x&quot;>10.1111/j.1365-2885.2008.00949.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18471142/&quot;>https://pubmed.ncbi.nlm.nih.gov/18471142</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Carbimazole;
